baicalin has been researched along with Cardiac Toxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eissa, LA; El-Ela, SRA; Zaghloul, RA | 1 |
| Feng, P; Liu, N; Wang, S; Yang, Y | 1 |
| Chu, L; Chu, X; Guan, S; Han, X; He, Q; Sun, X; Wang, X; Wu, Y; Wu, Z; Zhang, J; Zhang, M; Zhao, Y | 1 |
3 other study(ies) available for baicalin and Cardiac Toxicity
| Article | Year |
|---|---|
Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; beta Catenin; Biomarkers; Cardiotoxicity; Doxorubicin; Flavonoids; Mice; Myocardium; NF-kappa B; Oxidative Stress; Toll-Like Receptor 4 | 2022 |
Baicalin regulates TLR4/IκBα/NFκB signaling pathway to alleviate inflammation in Doxorubicin related cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotoxicity; Doxorubicin; Inflammation; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Rats; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Investigation of the ameliorative effects of baicalin against arsenic trioxide-induced cardiac toxicity in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Cardiotoxicity; Disease Models, Animal; Flavonoids; Humans; Inflammation; Male; Mice; NF-kappa B; Oxidative Stress; Scutellaria; Signal Transduction; Toll-Like Receptor 4 | 2021 |